New Study Links Common OTC Drug to Skin Cancer

By ·
New Study Links Common OTC Drug to Skin Cancer featured image
Photo Credits: Fuse/ Getty Images | Image Used for Illustrative Purpose Only

A new study published in the Journal of American Academy of Dermatology link men who use aspirin daily to an increased risk of potentially developing melanoma. In the study, the medical records of more than 195,000 non-melanoma patients ages 18 to 89 years old were studied over a five-year period. More than 1,100 of the patients were exposed to aspiring for one year, if not more.

You May Also Like: New Study Suggests There’s a Link Between White Wine and Melanoma

Research findings show that of the patients using aspirin, 2.19 percent developed melanoma compared to 0.86 percent of the non-aspirin exposed subjects. Men, in particular, are at risk for developing melanoma twice more than those not taking aspirin. And when women were assessed, those who take aspirin regularly did not have an elevated risk of melanoma.

A common over-the-counter pain reliever, up until now, there has been no association between aspirin and melanoma. But to further reduce the incidence, sun avoidance and sun safety, as well as regular skin checks and wearing sunscreen daily, should always be the first line of defense.

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.